Inventor · disambiguated record
Craig D. Logsdon
Also filed as: LOGSDON CRAIG · LOGSDON CRAIG D
4 granted patents·5 pending applications·25 citations·filing 2004–2019
69Inventor score
Top patents by PatentIndex Score
9 records- 0188US8252807B2Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-productsLOGSDON CRAIG D·Filed 2008·Granted Aug 28, 2012·21 cites·5 claims
- 0271US9439976B2Compositions and methods for using cathepsin E cleavable substratesTHE METHODIST HOSPITAL SYSTEM·Filed 2014·Granted Sep 13, 2016·3 cites·35 claims
- 0360US9265844B2Protease degradable polypeptides and uses thereofTUNG CHING-HSUAN·Filed 2011·Granted Feb 23, 2016·1 cites·42 claims
- 0453US2008214491A1Methods of Inhibiting the Interaction Between S100 and the Receptor for Advanced Glycation End-ProductsLOGSDON CRAIG D·Filed 2008·Application pending·0 cites
- 0548US2010249038A1Antagonists of the receptor for advanced glycation end-products (rage)UNIV TEXAS·Filed 2008·Application pending·0 cites
- 0647US2021340232A1Monoclonal antibodies against human dickkopf3 and uses thereofUNIV TEXAS·Filed 2019·Application pending·0 cites
- 0746US2011195924A1Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-ProductsLOGSDON CRAIG D·Filed 2009·Application pending·0 cites
- 0842US2005009067A1Expression profile of pancreatic cancerFiled 2004·Application pending·0 cites
- 0924US10428159B2Blocking monoclonal antibodies to AGR2 and its receptor C4.4AUNIV TEXAS·Filed 2015·Granted Oct 1, 2019·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →